BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 20362549)

  • 1. Adhesion-mediated self-renewal abilities of Ph+ blastoma cells.
    Funayama K; Saito-Kurimoto Y; Ebihara Y; Shimane M; Nomura H; Tsuji K; Asano S
    Biochem Biophys Res Commun; 2010 May; 396(2):193-8. PubMed ID: 20362549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
    Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
    Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation.
    Chiba T; Zheng YW; Kita K; Yokosuka O; Saisho H; Onodera M; Miyoshi H; Nakano M; Zen Y; Nakanuma Y; Nakauchi H; Iwama A; Taniguchi H
    Gastroenterology; 2007 Sep; 133(3):937-50. PubMed ID: 17673212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells.
    Chen T; Meng Z; Gan Y; Wang X; Xu F; Gu Y; Xu X; Tang J; Zhou H; Zhang X; Gan X; Van Ness C; Xu G; Huang L; Zhang X; Fang Y; Wu J; Zheng S; Jin J; Huang W; Xu R
    Leukemia; 2013 Jul; 27(7):1469-78. PubMed ID: 23307033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells.
    van Gosliga D; Schepers H; Rizo A; van der Kolk D; Vellenga E; Schuringa JJ
    Exp Hematol; 2007 Oct; 35(10):1538-49. PubMed ID: 17889721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.
    Holm F; Hellqvist E; Mason CN; Ali SA; Delos-Santos N; Barrett CL; Chun HJ; Minden MD; Moore RA; Marra MA; Runza V; Frazer KA; Sadarangani A; Jamieson CH
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15444-9. PubMed ID: 26621726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological characteristics of highly tumorigenic CD44+CD133+ subpopulation of laryngeal carcinoma cells].
    Yu D; Jin CS; Chen O; Wen LJ; Gao LF
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):99-103. PubMed ID: 19538883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer research. Mutant stem cells may seed cancer.
    Marx J
    Science; 2003 Sep; 301(5638):1308-10. PubMed ID: 12958339
    [No Abstract]   [Full Text] [Related]  

  • 10. Stem cells: Self-renewal writ in blood.
    Dick JE
    Nature; 2003 May; 423(6937):231-3. PubMed ID: 12748623
    [No Abstract]   [Full Text] [Related]  

  • 11. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
    Yang YM; Chang JW
    Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
    Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
    Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Arrestin1 promotes the self-renewal of the leukemia-initiating cell-enriched subpopulation in B-lineage acute lymphoblastic leukemia related to DNMT1 activity.
    Shu Y; Zhou X; Qi X; Liu S; Li K; Tan J; Liu Z; Yu J; Zhang P; Zou L
    Cancer Lett; 2015 Feb; 357(1):170-178. PubMed ID: 25444908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence for adhesion-mediated acquisition of acute myeloid leukemic stem cell-like immaturities.
    Funayama K; Shimane M; Nomura H; Asano S
    Biochem Biophys Res Commun; 2010 Feb; 392(3):271-6. PubMed ID: 20060807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia.
    Bhattacharyya J; Mihara K; Yasunaga S; Tanaka H; Hoshi M; Takihara Y; Kimura A
    Ann Hematol; 2009 Apr; 88(4):333-40. PubMed ID: 18781299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling.
    Siapati EK; Papadaki M; Kozaou Z; Rouka E; Michali E; Savvidou I; Gogos D; Kyriakou D; Anagnostopoulos NI; Vassilopoulos G
    Br J Haematol; 2011 Jan; 152(2):164-74. PubMed ID: 21118196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy.
    Zhou X; Zhou S; Li B; Li Q; Gao L; Li D; Gong Q; Zhu L; Wang J; Wang N; Huang L; Zhao L; Li Z; Zhou J
    Blood; 2015 Sep; 126(12):1433-42. PubMed ID: 26224647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
    Gerby B; Veiga DF; Krosl J; Nourreddine S; Ouellette J; Haman A; Lavoie G; Fares I; Tremblay M; Litalien V; Ottoni E; Kosic M; Geoffrion D; Ryan J; Maddox PS; Chagraoui J; Marinier A; Hébert J; Sauvageau G; Kwok BH; Roux PP; Hoang T
    J Clin Invest; 2016 Dec; 126(12):4569-4584. PubMed ID: 27797342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.